搜索临床试验以:Eylea(阿柏西普,BAY86-5321)
总计274个结果
-
Washington University School of MedicineRegeneron Pharmaceuticals完全的
-
Sunnybrook Health Sciences Centre未知年龄相关性黄斑变性 | 中心性浆液性脉络膜视网膜病变 | 特发性息肉状脉络膜血管病变加拿大
-
University of California, San DiegoRegeneron Pharmaceuticals完全的
-
Wills EyeRegeneron Pharmaceuticals完全的
-
Pusan National University HospitalNovartis未知
-
Tennessee RetinaRegeneron Pharmaceuticals未知
-
Gregg T. Kokame, MDRegeneron Pharmaceuticals完全的
-
Regeneron Pharmaceuticals尚未招聘视力障碍 | 糖尿病性黄斑水肿 (DME) | 新生血管性年龄相关性黄斑变性 (nAMD) | 湿性年龄相关性黄斑变性 (AMD)
-
Odense University HospitalZealand University Hospital; Queen's University, Belfast; Synoptik-Fonden; AP Moeller Foundation; ... 和其他合作者完全的
-
Unity Health Toronto完全的
-
Northern California Retina Vitreous AssociatesRegeneron Pharmaceuticals完全的
-
Hyewon ChungBayer未知
-
Regeneron Pharmaceuticals终止
-
M. Ali Khan, MDUniversity of California, Los Angeles; Southeastern Retina Associates; Eye Associates of New Mexico招聘中
-
Novartis Pharmaceuticals完全的年龄相关性黄斑变性美国, 奥地利, 捷克语, 意大利, 台湾, 比利时, 德国, 澳大利亚, 以色列, 加拿大, 法国, 西班牙, 大韩民国, 英国, 葡萄牙, 荷兰, 瑞典, 阿根廷, 马来西亚, 瑞士
-
Northern California Retina Vitreous AssociatesRegeneron Pharmaceuticals完全的糖尿病性黄斑水肿
-
Jaeb Center for Health ResearchNational Eye Institute (NEI); National Institutes of Health (NIH); Regeneron Pharmaceuticals完全的
-
The Emmes Company, LLCNational Eye Institute (NEI); University of Wisconsin, Madison; Milton S. Hershey Medical Center完全的
-
Genzyme, a Sanofi Company终止
-
Retina-Vitreous Associates Medical Group完全的有临床意义的糖尿病性黄斑水肿
-
Regeneron Pharmaceuticals完全的糖尿病性黄斑水肿 | 新生血管性年龄相关性黄斑变性美国
-
Greater Houston Retina ResearchThe Cleveland Clinic; Regeneron Pharmaceuticals完全的
-
Novartis Pharmaceuticals完全的
-
Ophthalmic Consultants of Long IslandRegeneron Pharmaceuticals完全的
-
Singapore National Eye CentreNational University Hospital, Singapore; Tan Tock Seng Hospital主动,不招人
-
H. Lee Moffitt Cancer Center and Research InstituteRegeneron Pharmaceuticals; Genzyme, a Sanofi Company招聘中
-
Genzyme, a Sanofi Company终止